The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2026. Part VIIIA – Basic prices of drugs Contractors should note changes made to the notes to Part VIIIA regarding Categories A, C, H and M. [...]
The post Drug Tariff Watch – March 2026 appeared first on Community Pharmacy England.
As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff funding and regulatory experts have created a new video on out-of-pocket (OOP) expenses. In this video, we explain how pharmacy teams can claim out-of-pocket expenses incurred when obtaining eligible drugs or appliances for dispensing against NHS prescriptions. We also cover [...]
The post Funding & Reimbursement Shorts: Out-of-pocket (OOP) expenses appeared first on Community Pharmacy England.
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]
The post Drug Tariff Watch – February 2026 appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd) Drug alert number: EL(26)A/04 Date issued: 28 January 2026 Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle. DMRC reference number:DMRC-38220370 Marketing [...]
The post MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd) appeared first on Community Pharmacy England.
MHRA Class 3 Medicines Recall: Prednisolone 5mg Soluble Tablets (Activase Pharmaceuticals Limited) Drug Alert Number: EL(25)A/54 Date issued: 15 December 2025 Activase Pharmaceuticals Limited is recalling two batches of Prednisolone 5mg Soluble Tablets as a precautionary measure due to a limited number of reports of blister pockets becoming swollen over time. DMRC reference number: DMRC – 37820855 [...]
The post MHRA Class 3 Medicines Recall: Prednisolone 5mg Soluble Tablets (Activase Pharmaceuticals Limited) appeared first on Community Pharmacy England.
Recent Comments